HR on NYSE
Healthcare Realty Trust Inc
Real estate investment trust, listed on NYSE (HR)1
In its 2026 annual report the company says: “Healthcare Realty Trust Incorporated is a self-managed and self-administered real estate investment trust that owns, leases, manages, acquires, finances, develops and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States.”4 It is headquartered in Nashville, Tennessee.1
Price unavailable
Last updated Oct 21, 2026.
Overview
Compare with FIRST REAL ESTATE INVESTMENT TRUST OF NEW JERSEY, INC., Seven Hills Realty Trust or Franklin BSP Realty Trust, Inc., or pick any stock.
- TickerHR on NYSE1
- IndustryReal Estate Investment Trusts1
- HeadquartersNashville, Tennessee1
- Business address3310 West End Avenue, Suite 700, Nashville, Tn 372032
- Filer categoryLarge accelerated filer2
See how the biggest companies compare on our leaderboards
Healthcare Realty Trust Incorporated is a self-managed and self-administered real estate investment trust (“REIT”) that owns, leases, manages, acquires, finances, develops and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. All references in this report to "Healthcare Realty," the "Company," "we," "us," or "our" mean Healthcare Realty Trust Incorporated together with its consolidated subsidiaries, including Healthcare Realty Holdings, L.P., or operating partnership (the "OP").4 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Management Fee Income brought in 70% of the revenue Healthcare Realty Trust Inc broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2023 | 2024 | 2025 |
|---|---|---|---|
| Management Fee Income | $7.5M | $9.8M | $19.6M |
| Parking Income | $9.9M | $9.3M | $8.6M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Other costs100¢$28.2M
Out of $28.2M in revenue.5 The company lost money this year.
Where each dollar of operating cash went, fiscal 2025
- Dividends paid85¢$386.9M
- Share buybacks1¢$4.0M
- Kept or used elsewhere14¢$66.2M
Out of $457.1M of cash from operations.5
Financial statements
Every line of the income statement as filed: the last 3 fiscal years, latest first.5
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Rental income | $1.1B | $1.2B | $1.3B |
| Interest income | $14.3M | $16.4M | $17.1M |
| Other operating | $28.2M | $19.2M | $17.5M |
| Total Revenue | $1.2B | $1.3B | $1.3B |
| Property operating | $449.1M | $473.4M | $500.4M |
| General and administrative | $72.6M | $83.1M | $58.4M |
| Transaction costs | $2.0M | $3.1M | $2.0M |
| Merger-related costs | $0 | $0 | -$2.0M |
| Depreciation and amortization | $564.0M | $675.2M | $730.7M |
| Total expenses | $1.1B | $1.2B | $1.3B |
| Gain on sales of real estate properties and other assets | $235.4M | $109.8M | $77.5M |
| Interest expense | -$209.0M | -$242.4M | -$258.6M |
| (Loss) gain on extinguishment of debt | -$451.0K | -$237.0K | $62.0K |
| Impairment of real estate properties and credit loss reserves | -$364.6M | -$313.5M | -$154.9M |
| Impairment of goodwill | $0 | -$250.5M | $0 |
| Equity loss from unconsolidated joint ventures | -$188.0K | -$135.0K | -$1.7M |
| Interest and other (expense) income, net | -$3.6M | -$260.0K | $1.3M |
| Total other income (expense) | -$342.4M | -$697.4M | -$336.2M |
| Net loss | -$249.5M | -$663.9M | -$282.1M |
| Net loss attributable to non-controlling interests | $3.4M | $9.4M | $3.8M |
| Net loss attributable to common stockholders | -$246.1M | -$654.5M | -$278.3M |
| Basic earnings per common share (in dollars per share) | -$0.71 | -$1.81 | -$0.74 |
| Diluted earnings per common share (in dollars per share) | -$0.71 | -$1.81 | -$0.74 |
| Weighted average common shares outstanding - basic (in shares) | 349.8M shares | 365.6M shares | 378.9M shares |
| Weighted average common shares outstanding - diluted (in shares) | 349.8M shares | 365.6M shares | 378.9M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.5
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Land | $1.1B | $1.1B | ||
| Buildings and improvements | $8.5B | $9.7B | ||
| Lease intangibles | $455.3M | $664.9M | ||
| Personal property | $7.1M | $9.9M | ||
| Investment in financing receivables, net | $123.2M | $123.7M | ||
| Financing lease right-of-use assets | $75.1M | $77.3M | ||
| Construction in progress | $0 | $32.0M | ||
| Land held for development | $57.5M | $52.4M | ||
| Total real estate investments | $10.3B | $11.8B | ||
| Less accumulated depreciation | -$2.4B | -$2.5B | ||
| Real estate assets held for sale, net 1 | $7.9B | $9.3B | ||
| Cash and cash equivalents | $26.2M | $68.9M | ||
| Assets held for sale, net | $143.6M | $12.9M | ||
| Operating lease right-of-use assets | $204.9M | $261.4M | ||
| Investments in unconsolidated joint ventures | $453.6M | $473.1M | ||
| Other assets, net | $487.8M | $507.5M | ||
| Total assets | $9.2B | $10.7B | ||
| Notes and bonds payable | $3.9B | $4.7B | ||
| Accounts payable and accrued liabilities | $211.1M | $222.5M | ||
| Liabilities of properties held for sale | $15.2M | $1.3M | ||
| Operating lease liabilities | $162.9M | $224.5M | ||
| Financing lease liabilities | $73.1M | $72.3M | ||
| Other liabilities | $160.5M | $161.6M | ||
| Total liabilities | $4.5B | $5.3B | ||
| Redeemable non-controlling interests | $3.3M | $4.8M | $3.9M | $2.0M |
| Preferred stock, $0.01 par value; 200,000 shares authorized; none issued and outstanding | $0 | $0 | ||
| Common stock, $0.01 par value; 1,000,000 shares authorized; 351,603 and 350,532 shares issued and outstanding at December 31, 2025 and 2024, respectively. | $3.5M | $3.5M | ||
| Additional paid-in capital | $9.1B | $9.1B | ||
| Accumulated other comprehensive loss | -$5.2M | -$1.2M | ||
| Cumulative net income attributable to common stockholders | $128.2M | $374.3M | ||
| Cumulative dividends | -$4.6B | -$4.3B | ||
| Total stockholders equity | $4.6B | $5.2B | ||
| Non-controlling interest | $56.5M | $66.2M | ||
| Total equity | $4.7B | $5.3B | $6.9B | $7.7B |
| Total liabilities, redeemable non-controlling interests, and stockholders' equity | $9.2B | $10.7B | ||
| Preferred stock, par value (in dollars per share) | $0.01 | $0.01 | ||
| Preferred stock, authorized (in shares) | 200.0M shares | 200.0M shares | ||
| Preferred stock, issued (in shares) | 0 shares | 0 shares | ||
| Preferred stock, outstanding (in shares) | 0 shares | 0 shares | 0 shares | |
| Common stock, par value (in dollars per share) | $0.01 | $0.01 | ||
| Common stock, authorized (in shares) | 1.0B shares | 1.0B shares | ||
| Common stock, issued (in shares) | 351.6M shares | 350.5M shares | ||
| Common stock, outstanding (in shares) | 351.6M shares | 350.5M shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Land | $1.1B | $1.1B | ||
| Buildings and improvements | $8.5B | $9.7B | ||
| Lease intangibles | $455.3M | $664.9M | ||
| Personal property | $7.1M | $9.9M | ||
| Investment in financing receivables, net | $123.2M | $123.7M | ||
| Financing lease right-of-use assets | $75.1M | $77.3M | ||
| Construction in progress | $0 | $32.0M | ||
| Land held for development | $57.5M | $52.4M | ||
| Total real estate investments | $10.3B | $11.8B | ||
| Less accumulated depreciation | -$2.4B | -$2.5B | ||
| Real estate assets held for sale, net 1 | $7.9B | $9.3B | ||
| Cash and cash equivalents | $26.2M | $68.9M | ||
| Assets held for sale, net | $143.6M | $12.9M | ||
| Operating lease right-of-use assets | $204.9M | $261.4M | ||
| Investments in unconsolidated joint ventures | $453.6M | $473.1M | ||
| Other assets, net | $487.8M | $507.5M | ||
| Total assets | $9.2B | $10.7B | ||
| Notes and bonds payable | $3.9B | $4.7B | ||
| Accounts payable and accrued liabilities | $211.1M | $222.5M | ||
| Liabilities of properties held for sale | $15.2M | $1.3M | ||
| Operating lease liabilities | $162.9M | $224.5M | ||
| Financing lease liabilities | $73.1M | $72.3M | ||
| Other liabilities | $160.5M | $161.6M | ||
| Total liabilities | $4.5B | $5.3B | ||
| Redeemable non-controlling interests | $3.3M | $4.8M | $3.9M | $2.0M |
| Preferred stock, $0.01 par value; 200,000 shares authorized; none issued and outstanding | $0 | $0 | ||
| Common stock, $0.01 par value; 1,000,000 shares authorized; 351,603 and 350,532 shares issued and outstanding at December 31, 2025 and 2024, respectively. | $3.5M | $3.5M | ||
| Additional paid-in capital | $9.1B | $9.1B | ||
| Accumulated other comprehensive loss | -$5.2M | -$1.2M | ||
| Cumulative net income attributable to common stockholders | $128.2M | $374.3M | ||
| Cumulative dividends | -$4.6B | -$4.3B | ||
| Total stockholders equity | $4.6B | $5.2B | ||
| Non-controlling interest | $56.5M | $66.2M | ||
| Total equity | $4.7B | $5.3B | $6.9B | $7.7B |
| Total liabilities, redeemable non-controlling interests, and stockholders' equity | $9.2B | $10.7B | ||
| Preferred stock, par value (in dollars per share) | $0.01 | $0.01 | ||
| Preferred stock, authorized (in shares) | 200.0M shares | 200.0M shares | ||
| Preferred stock, issued (in shares) | 0 shares | 0 shares | ||
| Preferred stock, outstanding (in shares) | 0 shares | 0 shares | 0 shares | |
| Common stock, par value (in dollars per share) | $0.01 | $0.01 | ||
| Common stock, authorized (in shares) | 1.0B shares | 1.0B shares | ||
| Common stock, issued (in shares) | 351.6M shares | 350.5M shares | ||
| Common stock, outstanding (in shares) | 351.6M shares | 350.5M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.5
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net loss | -$249.5M | -$663.9M | -$282.1M |
| Depreciation and amortization | $564.0M | $675.2M | $730.7M |
| Other amortization | $47.2M | $47.2M | $45.2M |
| Share-based compensation | $22.4M | $31.8M | $14.3M |
| Amortization of straight-line rent receivable (lessor) | -$27.1M | -$30.0M | -$38.7M |
| Amortization of straight-line rent on operating leases (lessee) | $3.4M | $3.9M | $6.1M |
| Loss on derivatives | $4.3M | $0 | $0 |
| Gain on sales of real estate properties and other assets | -$235.4M | -$109.8M | -$77.5M |
| Loss (gain) on extinguishment of debt | $451.0K | $237.0K | -$62.0K |
| Impairment of real estate properties and credit loss reserves | $364.6M | $313.5M | $154.9M |
| Impairment of goodwill | $0 | $250.5M | $0 |
| Equity loss from unconsolidated joint ventures | $188.0K | $135.0K | $1.7M |
| Distributions from unconsolidated joint ventures | $21.5M | $10.5M | $17.9M |
| Non-cash interest from financing and real estate notes receivable | -$1.1M | -$1.8M | -$1.7M |
| Other assets, including right-of-use-assets | -$31.5M | -$34.5M | -$55.9M |
| Accounts payable and accrued liabilities | -$25.5M | $5.2M | -$18.8M |
| Other liabilities | -$828.0K | $3.5M | $3.8M |
| Net cash provided by operating activities | $457.1M | $501.6M | $499.8M |
| Acquisitions of real estate | -$100.0K | $0 | -$49.2M |
| Development of real estate | -$12.6M | -$70.3M | -$41.1M |
| Additional long-lived assets | -$330.2M | -$249.0M | -$231.0M |
| Funding of mortgages and notes receivable | -$8.5M | -$5.5M | -$26.8M |
| Investments in unconsolidated joint ventures | -$2.2M | $0 | -$3.8M |
| Investment in financing receivable | -$502.0K | -$511.0K | -$1.8M |
| Proceeds from sales of real estate properties and additional long-lived assets | $1.0B | $1.2B | $701.4M |
| Contributions from redeemable non-controlling interests | $0 | $13.0K | $1.4M |
| Proceeds from insurance recovery | $2.0M | $0 | $0 |
| Proceeds from notes receivable repayments | $58.3M | $5.2M | $0 |
| Net cash provided by investing activities | $710.8M | $900.9M | $349.1M |
| Borrowings on unsecured credit facility | $1.4B | $1.3B | $694.0M |
| Repayments on unsecured credit facility | -$1.3B | -$1.3B | -$1.1B |
| Repayment on term loans | -$650.1M | -$350.0M | $0 |
| Repayments of notes and bonds payable | -$266.4M | -$25.5M | -$19.1M |
| Dividends paid | -$386.9M | -$457.9M | -$472.2M |
| Net proceeds from issuance of common stock | $0 | $104.0K | $130.0K |
| Common stock redemptions | -$4.0M | -$8.9M | -$2.3M |
| Common stock repurchases | $0 | -$510.4M | $0 |
| Distributions to non-controlling interest holders | -$4.9M | -$5.5M | -$5.1M |
| Redemption of non-controlling interest | -$834.0K | -$744.0K | $0 |
| Settlement of interest rate swaps | -$4.3M | $0 | $0 |
| Debt issuance and assumption costs | -$13.1M | -$563.0K | -$529.0K |
| Payments made on finance leases | -$53.0K | -$17.0K | -$17.0K |
| Net cash used in financing activities | -$1.2B | -$1.4B | -$884.2M |
| (Decrease) increase in cash and cash equivalents | -$42.7M | $43.2M | -$35.3M |
| Interest paid | $176.6M | $202.5M | $216.0M |
| Mortgage notes payable assumed in connection with acquisition of real estate, net | $0 | $0 | $5.3M |
| Invoices accrued for construction, tenant improvements and other capitalized costs | $55.8M | $40.0M | $31.5M |
| Capitalized interest | $12.1M | $4.3M | $3.0M |
| Mortgage notes receivable taken in connection with sale of real estate | $11.8M | $9.6M | $51.0M |
| Non-controlling interest in sale of real estate | $0 | $11.2M | $0 |
| Contribution of real estate properties into unconsolidated joint venture | $0 | $172.7M | $0 |
No quarter-by-quarter statement was filed.
Corporate structure
Healthcare Realty Trust Inc sits at the top of its group. 6 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of Healthcare Realty Trust Inc
- VANGUARD CAPITAL MANAGEMENT LLC Filed SCHEDULE 13G on Healthcare Realty Trust Inc, latest Apr 30, 2026
- VANGUARD PORTFOLIO MANAGEMENT LLC Filed SCHEDULE 13G on Healthcare Realty Trust Inc, latest Apr 29, 2026
- VANGUARD GROUP INC Filed SCHEDULE 13G/A on Healthcare Realty Trust Inc, latest Mar 27, 2026 (4 filings since Feb 10, 2022)
- State Street Corporation Filed SCHEDULE 13G on Healthcare Realty Trust Inc, latest Feb 9, 2026 (3 filings since Feb 1, 2023)
- Cohen & Steers Filed SCHEDULE 13G/A on Healthcare Realty Trust Inc, latest Nov 14, 2025 (5 filings since Feb 14, 2022)
- Starboard Value LP Filed SCHEDULE 13D/A on Healthcare Realty Trust Inc, latest Sep 25, 2025 (3 filings since Nov 26, 2024)
- Bank of America Filed SCHEDULE 13G/A on Healthcare Realty Trust Inc, latest Feb 14, 2025 (2 filings since Nov 14, 2024)
- BlackRock Filed SC 13G/A on Healthcare Realty Trust Inc, latest Jan 24, 2024 (4 filings since Feb 3, 2022)
- PRINCIPAL REAL ESTATE INVESTORS LLC Filed SC 13G/A on Healthcare Realty Trust Inc, latest Feb 15, 2023 (2 filings since Feb 15, 2022)
- APG Asset Management US Inc. Filed SC 13G/A on Healthcare Realty Trust Inc, latest Jan 12, 2023 (2 filings since Jan 19, 2022)
- Healthcare Realty Trust Inc Nashville, Tennessee
- Healthcare Acquisition of Subsidiary · Texas, United States
- HR Acquisition of Subsidiary · Pennsylvania, United States
- HR of Subsidiary · California, United States
- HRT of Subsidiary · Alabama, United States
- HRT Properties of Subsidiary · Texas, United States
Built from subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What Healthcare Realty Trust Inc reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Land | $1.1B5 Dec 31, 2025 | $1.1B5 Dec 31, 2024 | −7.3% |
| Operating-lease assets (leased space) | $204.9M5 Dec 31, 2025 | $261.4M5 Dec 31, 2024 | −21.6% |
Real estate and locations
| Item | Latest | A year before | Change |
|---|---|---|---|
| Real estate investments, net | $7.9B5 Dec 31, 2025 | $9.3B5 Dec 31, 2024 | −15.4% |
| Real estate investments, at cost | $10.3B5 Dec 31, 2025 | $11.8B5 Dec 31, 2024 | −12.9% |
| Real estate accumulated depreciation | $2.4B5 Dec 31, 2025 | $2.5B5 Dec 31, 2024 | −3.5% |
| Real estate properties | 5025 Dec 31, 2025 | 5899 Dec 31, 2024 | −14.8% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $26.2M5 Dec 31, 2025 | $68.9M5 Dec 31, 2024 | −62.0% |
| Loans, net of allowance | $123.2M5 Dec 31, 2025 | $123.7M5 Dec 31, 2024 | −0.3% |
Intangibles and goodwill
Properties, in its own words
In addition to the properties described in Item 1. “Business,” in Note 2 to the Consolidated Financial Statements, and in Schedule III of Item 15 of this Annual Report on Form 10-K, the Company leases office space from unrelated third parties from time to time. The Company owns its corporate headquarters located at 3310 West End Avenue in Nashville, Tennessee.
Item 2 of the 10-K filed Feb 13, 2026.4
Leadership
Who has led Healthcare Realty Trust Inc, and when. Pick a name to see everywhere that person has worked.
Chief financial officer
Chief operating officer
2010201520202025
- Chief executive officerConstance B. Moore Dec 11, 2024 to now13
- Chief executive officerTodd J. Meredith Jul 22, 2022 to Feb 14, 202414
- Chief executive officerScott D. Peters Apr 30, 2008 to Jan 5, 202115
- ChairScott D. Peters Apr 30, 2008 to Jul 6, 200915
- PresidentConstance B. Moore Dec 11, 2024 to now13
- PresidentTodd J. Meredith Jul 22, 2022 to Feb 14, 202414
- PresidentScott D. Peters Apr 30, 2008 to Jul 6, 200915
- Chief financial officerDaniel Gabbay Feb 25, 2026 to now16
- Chief financial officerAusten B. Helfrich Oct 7, 2024 to Feb 25, 202617
- Chief financial officerJ. Christopher Douglas Jul 22, 2022 to Feb 14, 202418
- Chief financial officerRobert A. Milligan Jan 2, 2015 to Jul 20, 202219
- Chief financial officerKellie S. Pruitt May 26, 2010 to Jan 3, 201420
- Chief financial officerShannon Kathleen S. Johnson Apr 30, 2008 to Apr 30, 200821
- Chief operating officerRobert E. Hull Dec 13, 2024 to now22
Board members and other officers (36)
- EVP and CIORyan E. Crowley Oct 7, 2024 to now23
- SVP & Chief Accounting OfficerAmanda L. Callaway Jul 22, 2022 to now24
- EVP - OperationsJulie F. Wilson Jul 22, 2022 to now25
- EVP - InvestmentsRobert E. Hull Jul 22, 2022 to Feb 14, 202426
- EVP - Corporate FinanceRobert A. Milligan Jul 9, 2014 to Jul 9, 201427
- EVP ? Asset ManagementAmanda Houghton Dec 16, 2011 to Jul 20, 202228
- Chief Accounting OfficerKellie S. Pruitt Feb 18, 2009 to Jul 31, 200929
- EVP - AcquisitionsMark David Engstrom Jul 13, 2009 to Jan 3, 201730
- EVP and SecretaryAndrea R. Biller Apr 30, 2008 to Apr 30, 200831
- Executive VP of AcquisitionsDanny Prosky Apr 30, 2008 to Apr 30, 200832
- Board memberThomas N. Bohjalian Jun 27, 2024 to now33
- Board memberDonald C. Wood Dec 16, 2024 to now34
- Board memberGlenn J. Rufrano Dec 16, 2024 to now35
- Board memberConstance B. Moore Mar 14, 2022 to now36
- Board memberReshma Block Mar 14, 2022 to Mar 14, 202237
- Board memberChristann M. Vasquez Jul 22, 2022 to now38
- Board memberEdward Hall Braman Jul 22, 2022 to Jun 27, 202339
- Board memberJames Joseph Kilroy Iv. Jul 22, 2022 to now40
- Board memberJohn Knox Singleton Jul 22, 2022 to Sep 6, 202441
- Board memberNancy H. Agee Jul 22, 2022 to now42
- Board memberPeter F. Lyle Sr. Jul 22, 2022 to now43
- Board memberTodd J. Meredith Jul 22, 2022 to Feb 14, 202414
- Board memberHenry Lee Cooper Jan 9, 2020 to Jul 9, 202144
- Board memberJay P. Leupp Jan 9, 2020 to now45
- Board memberRoberta B. Bowman Mar 16, 2018 to Jul 9, 201846
- Board memberVicki U. Booth Mar 16, 2018 to May 22, 202447
- Board memberDaniel S. Henson Apr 29, 2016 to Jul 9, 201948
- Board memberSteve W. Patterson Apr 30, 2014 to Jul 10, 201549
- Board memberScott D. Peters Jul 1, 2010 to Jan 5, 202150
- Board memberGary T. Wescombe Apr 30, 2008 to Jul 9, 202051
- Board memberLarry Mathis Apr 30, 2008 to Jul 9, 201952
- Board memberMaurice J. Dewald Apr 30, 2008 to Jul 9, 201953
- Board memberW. Bradley Blair Ii. Apr 30, 2008 to Jun 27, 202354
- Board memberWarren D. Fix Apr 30, 2008 to Jul 9, 202155
- General counselAndrew Edward Loope Jan 8, 2025 to now56
- General counselJohn M. Bryant Jr. Jul 22, 2022 to Jan 3, 202557
Subsidiaries and ownership
Subsidiaries (Exhibit 21)
- HR Acquisition of Pennsylvania, LLC PA3
- HR of California, LLC AL3
- HRT Properties of Texas, Ltd. TX3
- HRT of Alabama, LLC AL3
- Healthcare Acquisition of Texas, LLC AL3
The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.
Former names
Timeline
- Jul 31, 20268-K Other events58
- Jul 30, 20268-K Results of operations; Regulation FD disclosure59
- May 20, 20268-K Shareholder vote60
- May 19, 20268-K Entered a material agreement; New debt or obligation61
- May 7, 20268-K Entered a material agreement; New debt or obligation; Unregistered sale of shares62
- May 5, 20268-K Other events63
- Apr 30, 20268-K Results of operations; Regulation FD disclosure64
- Feb 27, 20268-K Regulation FD disclosure65
- Feb 23, 20268-K Change of auditor66
- Feb 12, 20268-K Results of operations; Regulation FD disclosure67
- Jan 7, 20268-K Executive or director change; Regulation FD disclosure68
- Dec 17, 20258-K Entered a material agreement69
- Dec 11, 2024New chief executive Constance B. Moore becomes CEO13
- Jul 22, 2022New chief executive Todd J. Meredith becomes CEO14
- Apr 30, 2008New chief executive Scott D. Peters becomes CEO15
Calendar
Coming up
- Oct 29, 2026 · After the closeReports results for the quarter ending Sep/2026 A year earlier it reported $0.41 a share, on Oct 30, 2025.70
When it reported results
- Jul 30, 2026Reported quarterly or annual results59
- Apr 30, 2026Reported quarterly or annual results64
- Feb 12, 2026Reported quarterly or annual results67
- Oct 30, 2025Reported quarterly or annual results71
- Jul 31, 2025Reported quarterly or annual results72
- May 1, 2025Reported quarterly or annual results73
- Feb 19, 2025Reported quarterly or annual results74
- Oct 30, 2024Reported quarterly or annual results75
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
382 filings to the SEC since October 2021: 6 annual reports, 15 quarterly reports, 86 major events, 186 insider forms, 27 large holders, 62 other. The latest 20:
- Sep 9, 20264 EDGAR
- Sep 8, 2026144 EDGAR
- Aug 11, 2026EFFECT EDGAR
- Jul 31, 2026S-3 EDGAR
- Jul 31, 20268-K EDGAR
- Jul 31, 2026424B5 EDGAR
- Jul 31, 2026S-3ASR EDGAR
- Jul 30, 202610-Q EDGAR
- Jul 30, 20268-K EDGAR
- Jun 23, 20264 EDGAR
- Jun 22, 2026144 EDGAR
- May 20, 20264 EDGAR
- May 20, 20264 EDGAR
- May 20, 20264 EDGAR
- May 20, 20268-K EDGAR
- May 20, 20264 EDGAR
- May 20, 20264 EDGAR
- May 19, 20268-K EDGAR
- May 7, 20268-K EDGAR
- May 5, 20268-K EDGAR
The 382 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
27 open-market trades by officers, directors and large owners since October 2021: 19 buys and 8 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 8, 2026 | Hull Robert EEVP and COO | Sale | 21,000 | $19.11 | $401.3K | Form 4 |
| Jun 23, 2026 | Callaway Amanda LSVP & Chief Accounting Officer | Sale | 25,767 | $20.37 | $524.9K | Form 4 |
| Mar 6, 2026 | Bohjalian Thomas NDirector | Buy | 10,000 | $18.09 | $180.9K | Form 4 |
| Mar 4, 2026 | Gabbay DanielEVP, Chief Financial Officer | Buy | 10 | $18.74 | $187 | Form 4 |
| Sep 5, 2025 | Wilson Julie F.EVP, Chief Admin. Officer | Sale | 15,000 | $18.00 | $270.0K | Form 4 |
| Aug 13, 2025 | Bohjalian Thomas NDirector | Buy | 10,000 | $16.46 | $164.6K | Form 4 |
| May 13, 2025 | Bohjalian Thomas NDirector | Buy | 2,500 | $14.71 | $36.8K | Form 4 |
| Dec 20, 2024 | Leupp Jay PDirector | Buy | 1,000 | $16.85 | $16.9K | Form 4 |
| Dec 19, 2024 | WOOD DONALD CDirector | Buy | 5,900 | $16.86 | $99.5K | Form 4 |
| Dec 17, 2024 | Hull Robert EEVP and COO | Sale | 10,000 | $17.48 | $174.8K | Form 4 |
| Dec 13, 2024 | Lyle Peter F SRDirector | Buy | 10,000 | $17.21 | $172.1K | Form 4 |
| Nov 22, 2024 | Bohjalian Thomas NDirector | Buy | 4,000 | $17.20 | $68.8K | Form 4 |
| Nov 22, 2024 | Bohjalian Thomas NDirector | Buy | 7,750 | $17.39 | $134.8K | Form 4 |
| Sep 5, 2024 | SINGLETON JOHN KNOXDirector | Buy | 6,500 | $18.25 | $118.6K | Form 4 |
| Sep 5, 2024 | Kilroy James Joseph IVDirector | Buy | 12,900 | $18.26 | $235.6K | Form 4 |
| Sep 4, 2024 | Bohjalian Thomas NDirector | Buy | 14,000 | $17.88 | $250.3K | Form 4 |
| Aug 30, 2024 | Lyle Peter F SRDirector | Buy | 1,272 | $17.74 | $22.6K | Form 4 |
| Aug 29, 2024 | Lyle Peter F SRDirector | Buy | 228 | $17.54 | $4.0K | Form 4 |
| Aug 20, 2024 | Bohjalian Thomas NDirector | Buy | 6,000 | $17.45 | $104.7K | Form 4 |
| Aug 12, 2024 | Bohjalian Thomas NDirector | Buy | 9,000 | $17.39 | $156.5K | Form 4 |
All 27 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- VANGUARD CAPITAL MANAGEMENT LLCSCHEDULE 13G, 1 filing Apr 30, 202676
- VANGUARD PORTFOLIO MANAGEMENT LLCSCHEDULE 13G, 1 filing Apr 29, 202677
- VANGUARD GROUP INCSCHEDULE 13G/A, 4 filings Feb 10, 2022 to Mar 27, 202678
- State Street CorporationSCHEDULE 13G, 3 filings Feb 1, 2023 to Feb 9, 202679
- Cohen & SteersSCHEDULE 13G/A, 5 filings Feb 14, 2022 to Nov 14, 202580
- Starboard Value LPSCHEDULE 13D/A, 3 filings Nov 26, 2024 to Sep 25, 202581
- Bank of AmericaSCHEDULE 13G/A, 2 filings Nov 14, 2024 to Feb 14, 202582
- BlackRockSC 13G/A, 4 filings Feb 3, 2022 to Jan 24, 202483
- PRINCIPAL REAL ESTATE INVESTORS LLCSC 13G/A, 2 filings Feb 15, 2022 to Feb 15, 202384
- APG Asset Management US Inc.SC 13G/A, 2 filings Jan 19, 2022 to Jan 12, 202385
Executive pay
What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.
| Year | Executive | Age | Salary | Total pay |
|---|---|---|---|---|
| 2025 | Peter A. ScottPresident and Chief Executive Officer, effective April 15, 2025 | $534.1K | $12.9M86 | |
| 2025 | Robert E. HullExecutive Vice President and Chief Operating Officer | $500.0K | $4.7M86 | |
| 2025 | Austen B. HelfrichFormer Executive Vice President and Chief Financial Officer, effective October 1, 2024 through January 11, 2026 | $405.0K | $3.8M86 | |
| 2025 | Ryan E. CrowleyExecutive Vice President and Chief Investments Officer, effectiv e October 1, 2024 | $450.0K | $3.7M86 | |
| 2025 | Julie F. WilsonFormer Executive Vice President and Chief Administrative Officer through December 31, 2025 | $450.0K | $3.5M86 | |
| 2025 | Andrew E. LoopeExecutive Vice President, General Counsel, and Secretary, effective January 1, 2025 | $450.0K | $2.8M86 | |
| 2025 | Constance B. MooreFormer Interim President and Chief Executive Officer, effective November 11, 2024 through April 14, 2025 | $705.0K86 | ||
| 2024 | Robert E. HullExecutive Vice President and Chief Operating Officer | $500.0K | $2.8M86 | |
| 2024 | Julie F. WilsonFormer Executive Vice President and Chief Administrative Officer through December 31, 2025 | $450.0K | $2.5M86 | |
| 2024 | Constance B. MooreFormer Interim President and Chief Executive Officer, effective November 11, 2024 through April 14, 2025 | $363.8K | $2.1M86 | |
| 2024 | Ryan E. CrowleyExecutive Vice President and Chief Investments Officer, effectiv e October 1, 2024 | $287.5K | $1.5M86 | |
| 2024 | Austen B. HelfrichFormer Executive Vice President and Chief Financial Officer, effective October 1, 2024 through January 11, 2026 | $327.0K | $845.9K86 | |
| 2023 | Robert E. HullExecutive Vice President and Chief Operating Officer | $500.0K | $2.5M86 | |
| 2023 | Julie F. WilsonFormer Executive Vice President and Chief Administrative Officer through December 31, 2025 | $450.0K | $2.3M86 |
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| BlackRock, Inc. | 57,045,264 | $1.2B | 0.0% | +2,200,701 |
| Vanguard Portfolio Management LLC | 29,049,740 | $585.9M | 0.0% | +426,341 |
| State Street Corp | 16,743,817 | $337.7M | 0.0% | −326,118 |
| Vanguard Capital Management LLC | 15,579,097 | $314.2M | 0.0% | +7,007 |
| Resolution Capital Ltd | 12,135,370 | $244.8M | 4.5% | −1,898,997 |
| APG Asset Management US Inc. | 10,223,995 | $207.4M | 1.5% | No change |
| Daiwa Securities Group Inc. | 8,105,312 | $163.5M | 0.4% | −317,663 |
| Charles Schwab Investment Management Inc | 7,440,510 | $150.1M | 0.0% | +109,754 |
| Geode Capital Management, LLC | 7,305,359 | $147.4M | 0.0% | +44,345 |
| Rush Island Management, LP | 5,213,764 | $105.2M | 7.0% | −2,011,598 |
| Dimensional Fund Advisors LP | 5,037,379 | $101.6M | 0.0% | +142,132 |
| Morgan Stanley | 5,014,723 | $101.1M | 0.0% | +646,180 |
| Los Angeles Capital Management LLC | 4,835,207 | $97.5M | 0.4% | +3,290,997 |
| Deutsche Bank Ag\ | 4,628,839 | $93.4M | 0.0% | +4,408,481 |
| Massachusetts Financial Services Co /ma/ | 4,026,952 | $88.2M | 0.0% | −245,706 |
| Aqr Capital Management LLC | 4,287,335 | $86.5M | 0.0% | +1,323,240 |
| Norges Bank | 3,801,738 | $76.7M | 0.0% | New |
| Sei Investments Co | 3,739,790 | $75.4M | 0.1% | −203,076 |
| Millennium Management LLC | 3,480,885 | $70.2M | 0.0% | +1,186,016 |
| Northern Trust Corp | 3,472,303 | $70.0M | 0.0% | −25,825 |
| Bank of New York Mellon Corp | 3,425,504 | $69.1M | 0.0% | −111,283 |
| Russell Investments Group, Ltd. | 3,267,017 | $65.9M | 0.1% | +1,012,145 |
| Jupiter Asset Management Ltd | 3,209,167 | $64.7M | 0.3% | No change |
| Goldman Sachs Group Inc | 2,907,645 | $58.6M | 0.0% | −363,144 |
| Legal & General Group Plc | 2,829,701 | $57.1M | 0.0% | +1,282 |
13F reports cover disclosed long positions in U.S. stocks only.
SEC filer profile
How Healthcare Realty Trust Inc is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARHealthcare Realty Trust Inc1
- CIK0001360604
- Employer ID (EIN)20-47384674
- Filer statusLarge accelerated filer not an emerging growth company; not a smaller reporting company; not a shell company4
- Incorporated inMaryland4
- Fiscal year endsDecember 311
- Industry code (SIC)6798 Real Estate Investment Trusts1
- SEC reviewing officeOffice of Real Estate & Construction, Division of Corporation Finance1
- Business address3310 West End Avenue, Suite 700, Nashville, TN 372031
- Phone615-269-81751
- Shares outstanding342,719,760 as of Jul 27, 202611
- Public float$5.5B as of Jun 30, 20254
- AuditorBDO USA, P.C., Nashville, TN PCAOB ID 243; it also attests to the company’s internal control over financial reporting4
- On EDGAR sinceApr 28, 20061
- Filings1,447 in all: 8-K (476), 4 (391), 424B3 (63), 10-Q (61), SC 13G/A (54), 8-K/A (50), 3 (45), 424B5 (30)1
All 53 form types
UPLOAD (30), CORRESP (24), 10-K (20), DEF 14A (20), EFFECT (19), POS AM (17), 425 (16), DEFA14A (16), SC 13G (15), S-3ASR (10), S-11/A (9), 144 (7), ARS (7), FWP (5), SC TO-T/A (4), 10-K/A (3), 15-12G (3), 4/A (3), S-4 (3), S-4/A (3), S-8 (3), SC 14D9 (3), SC TO-C (3), SC TO-I/A (3), SC TO-T (3), SCHEDULE 13G (3), SCHEDULE 13G/A (3), 8-A12G (2), POS EX (2), PRE 14A (2), S-11 (2), 15-12B (1), 15-12B/A (1), 8-A12B (1), CERTNYS (1), NO ACT (1), POSASR (1), PRER14A (1), S-3 (1), S-3DPOS (1), SC 13D (1), SC 13D/A (1), SC 14D9/A (1), SC TO-I (1), SCHEDULE 13D/A (1)
- Latest filingsAnnual report (10-K) Feb 13, 2026
Quarterly report (10-Q) Jul 30, 2026
Proxy statement (DEF 14A) Apr 7, 2026
Latest 8-K (8-K) Jul 31, 2026
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| Class A Common Stock, $0.01 par value per share | HR | New York Stock Exchange |
From the cover page of the 10-K filed Feb 13, 2026 (Section 12(b) of the Exchange Act).4
Risk factors and legal proceedings
The risks Healthcare Realty Trust Inc names in Item 1A of its 10-K filed Feb 13, 2026: 42 risks under these headings, as written.4
- Risks relating to our business and operations
- The Company's expected results may not be achieved.
- The Company’s revenues depend on the ability of its tenants under its leases to generate sufficient income from their operations to make rental payments to the Company.
- The Company's results of operations have been and will continue to be impacted negatively by the Prospect Medical bankruptcy.
- Owning real estate and indirect interests in real estate is subject to inherent risks.
- The Company may incur impairment charges on its real estate properties or other assets.
- The Company has properties subject to purchase options that expose it to reinvestment risk and reduction in expected investment returns.
- If the Company is unable to promptly re-let its properties, if the rates upon such re-letting are significantly lower than the previous rates or if the Company is required to undertake significant expenditures or make significant leasing concessions to attract new tenants, then the Company’s business, consolidated financial condition and results of operations would be adversely affected.
- Certain of the Company’s properties are special purpose healthcare facilities and may not be easily adaptable to other uses.
- The Company has, and in the future may have more exposure to fixed rent escalators, which could lag behind inflation and the growth in operating expenses such as real estate taxes, utilities, insurance, and maintenance expense.
- The Company’s real estate investments are illiquid and the Company may not be able to sell properties strategically targeted for disposition.
- The Company is subject to risks associated with the development and redevelopment of properties.
The other 31 risks
- The Company may make material acquisitions and undertake developments and redevelopments that may involve the expenditure of significant funds and may not perform in accordance with management’s expectations.
- The Company is exposed to risks associated with geographic concentration.
- Many of the Company’s leases are dependent on the viability of associated health systems. Revenue concentrations relating to these leases expose the Company to risks related to the financial condition of the associated health systems.
- Many of the Company’s properties are held under ground leases. These ground leases contain provisions that may limit the Company’s ability to lease, sell, or finance these properties.
- The Company may experience uninsured or underinsured losses.
- Damage from catastrophic weather and other natural events, whether caused by climate change or otherwise, could result in losses to the Company.
- The Company faces risks associated with security breaches through cyber attacks, cyber intrusions, or otherwise, as well as other significant disruptions of its information technology networks and related systems.
- The Company has structured and may in the future structure acquisitions of property in exchange for limited partnership units of the OP on terms that could limit its liquidity or flexibility.
- Healthcare Realty Trust is a holding company with no direct operations and, as such, it relies on funds received from the OP to pay liabilities, and the interests of its stockholders will be structurally subordinated to all liabilities and obligations of the OP and its subsidiaries.
- The Company cannot assure you that it will be able to continue paying dividends at or above the rates previously paid.
- Pandemics and measures intended to prevent their spread or mitigate their severity could have a material adverse effect on the Company's business, results of operations, cash flows and financial condition.
- The Company's success depends, in part, on its ability to attract and retain talented employees. The loss of any one of the Company's key personnel or the inability to maintain appropriate staffing could adversely impact the Company's business.
- Risks relating to our capital structure and financings
- The Company has incurred significant debt obligations and may incur additional debt and increase leverage in the future.
- Covenants in the Company’s debt instruments limit its operational flexibility, and a breach of these covenants could materially affect the Company’s consolidated financial condition and results of operations.
- If lenders under the Unsecured Credit Facility fail to meet their funding commitments, the Company’s operations and consolidated financial position would be negatively impacted.
- The unavailability of equity and debt capital, volatility in the credit markets, increases in interest rates, or changes in the Company’s debt ratings could have an adverse effect on the Company’s ability to meet its debt payments, make dividend payments to stockholders or engage in acquisition and development activity.
- Increases in interest rates could have a material adverse effect on the Company's cost of capital.
- The Company's swap agreements may not effectively reduce its exposure to changes in interest rates.
- The Company has entered into joint venture agreements that limit its flexibility with respect to jointly owned properties and expects to enter into additional such agreements in the future.
- The U.S. federal income tax treatment of the cash that the Company might receive from cash settlement of a forward equity agreement is unclear and could jeopardize the Company's ability to meet the REIT qualification requirements.
- In the event of our bankruptcy or insolvency, any forward equity agreements will automatically terminate, and the Company would not receive the expected proceeds from any forward sale of shares of its common stock.
- Risks relating to government regulations
- The Company's property taxes could increase due to reassessment or property tax rate changes.
- Trends in the healthcare service industry, including the impact of the One Big Beautiful Bill Act passed during 2025 that is subject of ongoing analysis, may negatively affect the demand for the Company’s properties, lease revenues and the values of its investments.
- The costs of complying with governmental laws and regulations may adversely affect the Company's results of operations.
- Qualifying as a REIT involves highly technical and complex provisions of the Internal Revenue Code.
- If the Company fails to remain qualified as a REIT, the Company will be subject to significant adverse consequences, including adversely affecting the value of its common stock.
- The Company’s articles of incorporation, as well as provisions of the MGCL, contain limits and restrictions on transferability of the Company’s common stock which may have adverse effects on the value of the Company’s common stock.
- Complying with the REIT requirements may cause the Company to forego otherwise attractive opportunities.
- The prohibited transactions tax may limit the Company's ability to sell properties.
- New legislation or administrative or judicial action, in each instance potentially with retroactive effect, could make it more difficult or impossible for the Company to qualify as a REIT.
- New and increased transfer tax rates may reduce the value of the Company’s properties.
Legal proceedings
The Company is not aware of any pending or threatened litigation that, if resolved against the Company, would have a material adverse effect on the Company's consolidated financial position, results of operations, or cash flows.
The opening of Item 3, Legal Proceedings.4
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23SEC EDGARRyan E. Crowley, EVP and CIO
- 24
- 25SEC EDGARJulie F. Wilson, EVP - Operations
- 26SEC EDGARRobert E. Hull, EVP - Investments
- 27
- 28
- 29
- 30
- 31SEC EDGARAndrea R. Biller, EVP and Secretary
- 32
- 33SEC EDGARThomas N. Bohjalian, Board member
- 34SEC EDGARDonald C. Wood, Board member
- 35SEC EDGARGlenn J. Rufrano, Board member
- 36SEC EDGARConstance B. Moore, Board member
- 37SEC EDGARReshma Block, Board member
- 38SEC EDGARChristann M. Vasquez, Board member
- 39SEC EDGAREdward Hall Braman, Board member
- 40
- 41SEC EDGARJohn Knox Singleton, Board member
- 42SEC EDGARNancy H. Agee, Board member
- 43SEC EDGARPeter F. Lyle Sr., Board member
- 44SEC EDGARHenry Lee Cooper, Board member
- 45SEC EDGARJay P. Leupp, Board member
- 46SEC EDGARRoberta B. Bowman, Board member
- 47SEC EDGARVicki U. Booth, Board member
- 48SEC EDGARDaniel S. Henson, Board member
- 49SEC EDGARSteve W. Patterson, Board member
- 50SEC EDGARScott D. Peters, Board member
- 51SEC EDGARGary T. Wescombe, Board member
- 52SEC EDGARLarry Mathis, Board member
- 53SEC EDGARMaurice J. Dewald, Board member
- 54SEC EDGARW. Bradley Blair Ii., Board member
- 55SEC EDGARWarren D. Fix, Board member
- 56SEC EDGARAndrew Edward Loope, General counsel
- 57SEC EDGARJohn M. Bryant Jr., General counsel
- 58SEC EDGAROther events
- 59
- 60SEC EDGARShareholder vote
- 61
- 62
- 63SEC EDGAROther events
- 64
- 65SEC EDGARRegulation FD disclosure
- 66SEC EDGARChange of auditor
- 67
- 68
- 69SEC EDGAREntered a material agreement
- 70NasdaqNasdaq calendar
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86